Mereo BioPharma investigated by Faruqi & Faruqi for securities fraud.

miércoles, 11 de febrero de 2026, 9:44 am ET1 min de lectura
MREO--

Faruqi & Faruqi, LLP is investigating Mereo BioPharma Group plc for potential securities fraud. Investors who purchased or acquired securities in Mereo between June 5, 2023 and December 26, 2025 are encouraged to contact Josh Wilson at 877-247-4292 or 212-983-9330 to discuss their options. The deadline to seek lead plaintiff status is April 6, 2026.

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios